Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
*BCL2 interacting protein 3 pseudogene 1 (BNIP3P1)* is a human pseudogene and does not encode a functional protein. It is related by sequence similarity to the true *BNIP3* gene (*BCL2/adenovirus E1B 19 kDa protein-interacting protein 3*), which is a BH3-only pro-apoptotic member of the BCL2 protein family involved in cell death, autophagy, and cancer. However, BNIP3P1 itself does not produce a receptor, enzyme, or any product that can serve as a drug target. Any literature or database entries discussing roles in apoptosis, autophagy, or disease are specific to the functional gene *BNIP3* and not the BNIP3P1 pseudogene. If you are interested in the functional *BNIP3* protein, please specify, as BNIP3 is a recognized pro-apoptotic BCL2 family protein with experimentally characterized roles and potential as a disease biomarker and research target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 1 (BNIP3P1).